Clinical impact of early brain atrophy in clinically isolated syndromes

Abstract

Background:

The impact of global and tissue-specific brain atrophy on conversion to multiple sclerosis (MS) after a clinically isolated syndrome (CIS) is not fully gauged.

Objectives:

We aimed to determine the magnitude and clinical relevance of brain volume dynamics in the first year after a CIS.

Methods:

We assessed 176 patients with CIS within 3 months of onset, clinically and by conventional magnetic resonance imaging (MRI) scans, at baseline and 1 year after clinical onset. We determined the percentage of brain volume change (PBVC) and the brain parenchymal (BPF), grey matter (GMF) and white matter (WMF) fractions.

Results:

The mean follow-up time was 53 months (SD = 16.8): 76 patients (43%) experienced a second attack, 32 (18%) fulfilled MRI-only 2005 McDonald criteria and 68 (39%) remained as CIS. Statistically significant decreases in the volume measures tested were observed in patients with a second attack, for BPF and PBVC; in both MS groups for GMF; whereas in all groups, the WMF was unchanged. Patients with a second attack had larger PBVC decreases (− 0.65% versus + 0.059%; p < 0.001). PBVC decreases below − 0.817% independently predicted shorter times to a second attack.

Conclusions:

Global brain and grey matter volume loss occurred within the first year after a CIS; brain volume loss predicted conversion to MS.

Keywords

Brain atrophy brain volume clinically isolated syndrome disability grey matter magnetic resonance imaging multiple sclerosis

Get full access to this article

View all access options for this article.

References

Bjartmar

Trapp

. Axonal and neuronal degeneration in multiple sclerosis: Mechanisms and functional consequences. Curr Opin Neurol 2001; 14: 271–278.

Miller

Barkhof

Frank

. Measurement of atrophy in multiple sclerosis: Pathological basis, methodological aspects and clinical relevance. Brain 2002; 125: 1676–1695.

Dalton

Chard

Davies

. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain 2004; 127: 1101–1107.

Sastre-Garriga

Ingle

Chard

. Grey and white matter changes in early primary progressive multiple sclerosis: A longitudinal study. Brain 2005; 128: 1454–1460.

Rudick

Lee

Nakamura

. Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS. J Neurol Sci 2009; 282: 106–111.

Calabrese

Rinaldi

Mattisi

. The predictive value of gray matter atrophy in clinically isolated syndromes. Neurology 2011; 77: 257–263.

Di Filippo Anderson

Altmann

. Brain atrophy and lesion load measures over 1 year relate to clinical status after 6 years in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry 2010; 81: 204–208.

Raz

Cercignami

Sbardella

. Gray- and white-matter changes 1 year after first clinical episode of multiple sclerosis: MR imaging. Radiology 2010; 257: 448–454.

Kalincik

Vaneckova

Tyblova

. Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: A longitudinal cohort study. PLoS One 2012; 7: e50101.

10.

Polman

Reingold

Edan

. Diagnostic criteria for multiple sclerosis: 2005 Revisions to the “McDonald Criteria.” Ann Neurol 2005; 58: 840–846.

11.

Kurtzke

. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33: 1444–1452.

12.

Woolrich

Jbabdi

Patenaude

. Bayesian analysis of neuroimaging data in FSL. Neuroimage 2009; 45: S173–186.

13.

Smith

Jenkinson

Woolrich

. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004; 23: S208–219.

14.

Perneger

. What’s wrong with Bonferroni adjustments. BMJ 1998; 316: 1236–1238.

15.

Chard

Griffin

Parker

GJM

. Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain 2002; 125: 327–337.

16.

Sastre-Garriga

Ingle

Chard

. Grey and white matter atrophy in early clinical stages of primary progressive multiple sclerosis. Neuroimage 2004; 22: 353–359.

17.

Fisher

Lee

Nakamura

. Gray matter atrophy in multiple sclerosis: A longitudinal study. Ann Neurol 2008; 64: 255–265.

18.

Fisniku

Chard

Jackson

. Gray matter atrophy is related to long-term disability in multiple sclerosis. Ann Neurol 2008; 64: 247–254.

19.

Calabrese

Atzori

Bernardi

. Cortical atrophy is relevant in multiple sclerosis at clinical onset. J Neurol 2007; 254: 1212–1220.

20.

Raz

Cercignami

Sbardella

. Clinically isolated syndrome suggestive of multiple sclerosis: Voxelwise regional investigation of white and gray matter. Radiology 2010; 254: 227–234.

21.

Raz

Rodrigue

. Differential aging of the brain: Patterns, cognitive correlates and modifiers. Neurosci Biobehav Rev 2006; 30: 730–748.

22.

Courchesne

Chisum

Townsend

. Normal brain development and aging: Quantitative analysis at in vivo MR imaging in healthy volunteers. Radiology 2000; 216: 672–682.

23.

Grossman

Babb

. Age-related total gray matter and white matter changes in normal adult brain. Part I: Volumetric MR imaging analysis. Am J Neuroradiol 2002; 23: 1327–1333.

24.

Horakova

Dwyer

Havrdova

. Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis. A 5-year longitudinal study. J Neurol Sci 2009; 282: 112–119.

25.

Roosendaal

Bendfeldt

Vrenken

. Grey matter volume in a large cohort of MS patients: Relation to MRI parameters and disability. Mult Scler 2011; 17: 1098–1106.

26.

Sierra-Marcos

Mitjana

Castilló

. Demyelinating lesions as incidental findings in magnetic resonance imaging. A study of 11 cases with clinico-radiological follow-up and a review of the literature. Rev Neurol 2010; 51: 129–134.

27.

Tintoré

Rovira

Río

. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? Neurology 2008; 70: 1079–1083.

28.

Polman

Reingold

Banwell

. Diagnostic criteria for multiple sclerosis: 2010 Revisions of the McDonald criteria. Ann Neurol 2011; 69: 292–302.

29.

Battaglini

Jenkinson

De Stefano

. Evaluating and reducing the impact of white matter lesions on brain volume measurements. Hum Brain Mapp 2012; 33: 2062–2071.

30.

Vrenken

Jenkinson

Horsfield

. Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis. J Neurol Epub ahead of print 12 Dec 2012. DOI 10.1007/s00415-012-6762-5.